• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用处方药物监测计划遏制阿肯色州的阿片类药物处方。

Leveraging the Prescription Drug Monitoring Program to Curb Opioid Prescribing in Arkansas.

机构信息

Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Healthcare System, 2200 Fort Roots Drive, Bldg. 58, North Little Rock, AR, 72114, USA.

Department of Biomedical Informatics, College of Medicine, University of Arkansas for Medical Sciences, 4301 West Markham Street, Slot 782, Little Rock, AR, 72205, USA.

出版信息

J Prev (2022). 2022 Jun;43(3):337-357. doi: 10.1007/s10935-022-00670-7. Epub 2022 Feb 3.

DOI:10.1007/s10935-022-00670-7
PMID:35286546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9117447/
Abstract

Effective means of accurately identifying problematic opioid prescribing are needed. Using an iterative approach with the Arkansas State Medical Board Pain Subcommittee, we modified existing opioid prescriber criteria to create seven metrics to be deployed in Arkansas. These included metrics of dose and days' supply, concomitant use of opioid and benzodiazepines, solid dosage units, and numbers of opioid patients and certain opioid prescriptions. Two of these metrics (average MME daily dose per prescription and total oxycodone 30 mg or hydromorphone prescriptions) were weighted by 2, creating a maximum score of 9 of which each prescriber could receive. Twenty prescribers with a score of 7 or greater were identified and referred to the Arkansas State Medical Board Pain Subcommittee for review and subsequent investigation if deemed necessary. Of those 20 prescribers, four were previously investigated and under disciplinary action, and three were under current investigation for misconduct related to prescribing practices. Five prescribers had new investigations opened due to the findings from the metrics, and disciplinary action was taken. Therefore, 12 of the 20 prescribers referred to the Arkansas State Medical Board were deemed worthy of investigation and disciplinary action. The Arkansas opioid prescriber metrics are able to accurately identify prescribers with potentially problematic opioid prescribing.

摘要

需要有效的方法来准确识别有问题的阿片类药物处方。我们与阿肯色州医学委员会疼痛小组委员会一起采用迭代方法,修改了现有的阿片类药物处方者标准,创建了将在阿肯色州部署的七个指标。这些指标包括剂量和供应天数、阿片类药物和苯二氮䓬类药物的同时使用、固体制剂单位、阿片类药物患者数量和某些阿片类药物处方数量。其中两个指标(每个处方的平均 MME 日剂量和总羟考酮 30 毫克或氢吗啡酮处方)的权重为 2,每个处方者的最高得分为 9。确定了 20 名得分在 7 分或以上的处方者,并将其转交给阿肯色州医学委员会疼痛小组委员会审查,如果认为有必要,随后进行调查。在这 20 名处方者中,有 4 名之前已经接受过调查和纪律处分,有 3 名目前因与处方实践相关的不当行为正在接受调查。由于这些指标的调查结果,有 5 名处方者的新调查已经展开,并采取了纪律处分措施。因此,在转交给阿肯色州医学委员会的 20 名处方者中,有 12 名被认为值得调查和采取纪律处分措施。阿肯色州阿片类药物处方者指标能够准确识别出可能存在问题的阿片类药物处方者。

相似文献

1
Leveraging the Prescription Drug Monitoring Program to Curb Opioid Prescribing in Arkansas.利用处方药物监测计划遏制阿肯色州的阿片类药物处方。
J Prev (2022). 2022 Jun;43(3):337-357. doi: 10.1007/s10935-022-00670-7. Epub 2022 Feb 3.
2
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.受控物质处方模式 - 处方行为监测系统,八个州,2013 年。
MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.
3
Validation of prescriber risk indicators obtained from prescription drug monitoring program data.从处方药监测项目数据中获取的开方者风险指标的验证
Drug Alcohol Depend. 2017 Apr 1;173 Suppl 1:S31-S38. doi: 10.1016/j.drugalcdep.2016.11.020.
4
An Examination of Concurrent Opioid and Benzodiazepine Prescribing in 9 States, 2015.9 个州 2015 年阿片类药物与苯二氮䓬类药物同时处方情况调查
Am J Prev Med. 2019 Nov;57(5):629-636. doi: 10.1016/j.amepre.2019.06.007. Epub 2019 Sep 27.
5
Prescribing Associated with High-Risk Opioid Exposures Among Non-cancer Chronic Users of Opioid Analgesics: a Social Network Analysis.阿片类镇痛药非癌症慢性使用者的高风险阿片类药物暴露相关处方:社会网络分析。
J Gen Intern Med. 2019 Nov;34(11):2443-2450. doi: 10.1007/s11606-019-05114-3. Epub 2019 Aug 16.
6
Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program.在俄勒冈州处方药物监测计划中,按医师类型划分的阿片类药物处方模式和患者结局。
Pain Med. 2018 Dec 1;19(12):2481-2486. doi: 10.1093/pm/pnx283.
7
Association Between Statewide Opioid Prescribing Interventions and Opioid Prescribing Patterns in North Carolina, 2006-2018.2006-2018 年北卡罗来纳州全州范围阿片类药物处方干预措施与阿片类药物处方模式的关联。
Pain Med. 2021 Dec 11;22(12):2931-2940. doi: 10.1093/pm/pnab181.
8
The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic.国家政策对初始阿片类镇痛药高危处方率的影响。
Drug Alcohol Depend. 2022 Feb 1;231:109232. doi: 10.1016/j.drugalcdep.2021.109232. Epub 2021 Dec 28.
9
Relationship between high-risk patients receiving prescription opioids and high-volume opioid prescribers.接受处方类阿片药物的高危患者与大剂量开处阿片类药物的医生之间的关系。
Addiction. 2018 Apr;113(4):677-686. doi: 10.1111/add.14068. Epub 2017 Nov 29.
10
Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.佛罗里达州的处方药监测计划和“药丸工厂”法对阿片类药物处方和使用的影响。
JAMA Intern Med. 2015 Oct;175(10):1642-9. doi: 10.1001/jamainternmed.2015.3931.

本文引用的文献

1
Opioid medication discontinuation and risk of adverse opioid-related health care events.阿片类药物停药与不良阿片类药物相关医疗事件风险。
J Subst Abuse Treat. 2019 Aug;103:58-63. doi: 10.1016/j.jsat.2019.05.001. Epub 2019 May 5.
2
Vital Signs: Trends in Emergency Department Visits for Suspected Opioid Overdoses - United States, July 2016-September 2017.生命体征:2016年7月至2017年9月美国疑似阿片类药物过量急诊就诊趋势
MMWR Morb Mortal Wkly Rep. 2018 Mar 9;67(9):279-285. doi: 10.15585/mmwr.mm6709e1.
3
Relationship between high-risk patients receiving prescription opioids and high-volume opioid prescribers.
接受处方类阿片药物的高危患者与大剂量开处阿片类药物的医生之间的关系。
Addiction. 2018 Apr;113(4):677-686. doi: 10.1111/add.14068. Epub 2017 Nov 29.
4
Suicidal ideation and suicidal self-directed violence following clinician-initiated prescription opioid discontinuation among long-term opioid users.长期阿片类药物使用者在临床医生启动处方类阿片药物停药后出现自杀意念和自杀自伤行为。
Gen Hosp Psychiatry. 2017 Jul;47:29-35. doi: 10.1016/j.genhosppsych.2017.04.011. Epub 2017 Apr 27.
5
Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy: A Systematic Review.长期阿片类药物治疗剂量减少或停药的患者结局:系统评价。
Ann Intern Med. 2017 Aug 1;167(3):181-191. doi: 10.7326/M17-0598. Epub 2017 Jul 11.
6
Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.生命体征:2006 - 2015年美国阿片类药物处方的变化
MMWR Morb Mortal Wkly Rep. 2017 Jul 7;66(26):697-704. doi: 10.15585/mmwr.mm6626a4.
7
Validation of prescriber risk indicators obtained from prescription drug monitoring program data.从处方药监测项目数据中获取的开方者风险指标的验证
Drug Alcohol Depend. 2017 Apr 1;173 Suppl 1:S31-S38. doi: 10.1016/j.drugalcdep.2016.11.020.
8
Managing Chronic Pain in Primary Care: It Really Does Take a Village.基层医疗中慢性疼痛的管理:确实需要众人协作。
J Gen Intern Med. 2017 Aug;32(8):931-934. doi: 10.1007/s11606-017-4047-5. Epub 2017 Mar 23.
9
Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use - United States, 2006-2015.2006 - 2015年美国初始处方事件的特征及长期使用阿片类药物的可能性
MMWR Morb Mortal Wkly Rep. 2017 Mar 17;66(10):265-269. doi: 10.15585/mmwr.mm6610a1.
10
Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United States.美国的非医疗处方阿片类药物使用及《精神疾病诊断与统计手册》第五版中的非医疗处方阿片类药物使用障碍
J Clin Psychiatry. 2016 Jun;77(6):772-80. doi: 10.4088/JCP.15m10386.